Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical preparation for treating coronary diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A pharmaceutical preparation, coronary heart disease technology, applied in the direction of drug combination, cardiovascular system diseases, medical preparations containing active ingredients, etc. , Accurate curative effect, quick effect
Inactive Publication Date: 2014-11-26
SHANDONG UNIV
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although domestic cardiologists have many treatment options, most of them have disadvantages such as unsatisfactory treatment effect, inability to cure, high cost, and complicated treatment process.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] Example 1 Preparation of pharmaceutical preparations for the treatment of coronary heart disease
[0024] The formula is: Polygonatum 25g, Cornus officinalis 13g, Uncaria 13g, fried jujube kernel 6g, Platycodon grandiflorum 6g, Radix ginseng 25g, Panax notoginseng 35g, Ligusticum chuanxiong 30g, Salvia miltiorrhiza 25g, Rehmannia glutinosa 13g, licorice 15 grams, 15 grams of Radix Paeoniae Alba, 10 grams of Rhizoma Imperatae, 25 grams of blood, 20 grams of Asarum, and 15 grams of Dijincao.
[0025] The preparation method is as follows: take various raw materials, dry grind them into fine powder, pass through a 300-mesh sieve, and put them into No. 1 capsules.
[0026] Usage and dosage: Take it orally, three times a day, after meals, 2 capsules each time, 10 days as a course of treatment.
Embodiment 2
[0027] Example 2 Preparation of pharmaceutical preparations for the treatment of coronary heart disease
[0028] The formula is: Polygonatum 22 grams, Cornus officinalis 12 grams, Uncaria 14 grams, fried jujube kernel 7 grams, bellflower 6 grams, ginseng 22 grams, Panax notoginseng 38 grams, Chuanxiong 32 grams, Salvia miltiorrhiza 20 grams, Rehmannia glutinosa 12 grams, licorice 18 grams, 18 grams of white peony root, 8 grams of rhizoma rhizome, 22 grams of blood, 22 grams of asarum, and 10 grams of Dijincao.
[0029] The preparation method is as follows: take various raw materials, dry grind them into fine powder, pass through a 300-mesh sieve, and put them into No. 1 capsules.
[0030] Usage and dosage: Take it orally, three times a day, after meals, 2 capsules each time, 10 days as a course of treatment.
Embodiment 3
[0031] Example 3 Preparation of pharmaceutical preparations for the treatment of coronary heart disease
[0032] The formula is: Polygonatum 28g, Cornus officinalis 14g, Uncaria 12g, fried jujube kernel 6g, Bellflower 7g, Radix Ginseng 28g, Panax notoginseng 32g, Rhizoma Chuanxiong 28g, Salvia miltiorrhiza 28g, Rehmannia glutinosa 14g, licorice 12 grams, 12 grams of Radix Paeoniae Alba, 13 grams of Rhizoma Imperatae, 30 grams of blood, 18 grams of Asarum, and 18 grams of Dijincao.
[0033] The preparation method is as follows: take various raw materials, dry grind them into fine powder, pass through a 300-mesh sieve, and put them into No. 1 capsules.
[0034] Usage and dosage: Take it orally, three times a day, after meals, 2 capsules each time, 10 days as a course of treatment.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a pharmaceutical preparation for treating coronary diseases, and the pharmaceutical preparation is composed of the following bulk pharmaceutical chemicals in parts by weight: 20-30 parts of radix polygonati officinalis, 10-15 parts of cornus officinalis, 10-15 parts of uncaria rhynchophylla, 5-8 parts of fried spina date seeds,, 5-8 parts of platycodon grandiflorum, 20-30 parts of roots of straight ladybell, 30-40 parts of notoginseng, 25-35 parts of rhizoma ligustici wallichii, 15-30 parts of salvia miltiorrhiza, 10-15 parts of prepared rhizome of rehmannia, 10-20 parts of licorice roots, 10-20 parts of radix paeoniae alba, 5-15 parts of rhizoma imperatae, 20-35 parts of sangusis draconis, 15-25 parts of asarum, and 5-20 parts of humifuse euphorbia herbs. In the process of treatment, the pharmaceutical preparation is taken orally, one period of treatment lasts 10 days, the pharmaceutical preparation takes effect generally after one period of treatment, and after 2-3 periods of treatment, patients get better or are rehabilitated. The pharmaceutical preparation disclosed by the invention has the following advantages: 1, the pharmaceutical preparation is a pure natural Chinese herbal medicine, therefore, the pharmaceutical preparation is small in toxic and side effects and unique in therapeutic effect; and 2, the pharmaceutical preparation takes effect quickly and has an exact curative effect, and the clinical application of more than 600 patients verifies that the effective rate can reach 96.6%.
Description
technical field [0001] The invention relates to a pharmaceutical preparation for treating coronary heart disease. Background technique [0002] Coronary artery heart disease (CHD), referred to as coronary heart disease, is the most common heart disease and refers to myocardial dysfunction and / or organic disease caused by coronary artery stenosis and insufficient blood supply. Therefore, it is also called ischemic cardiomyopathy (IHD). CHD is the result of various coronary artery diseases, but coronary atherosclerosis accounts for the vast majority (95%-99%) of coronary heart disease. Therefore, it is customary to regard coronary heart disease as coronary atherosclerosis Synonym for coronary atherosclerotic heart disease. [0003] Traditional Chinese medicine believes that the main manifestations of this disease are deficiency in origin and excess in superficiality, mixed excess and deficiency. The pathogenesis is obstruction of the heart vessels, and the disease location ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More